Is an innovative technology to mitigate the impact of the placebo response in clinical trials and empower drug development.
Tools4Patient aims to develop predictive tools that improve and accelerate the clinical evaluation of drugs and other therapeutics.
Accelerate clinical decision making
The pharmaceutical, biotechnology and medical device industries have been plagued by high rates of failure in Phase 2 and Phase 3 due to inability to demonstrate therapeutic efficacy. Over time, this has resulted in clinical trials that are longer, more expensive and more burdensome for patients.
Tools4Patient has developed technologies to improve clinical data analysis and empower clinical decision making, with the ultimate goal of accelerating the delivery of much-needed drugs to patients. Our first product, Placebell©™, improves the ability to detect true therapeutic efficacy by reducing clinical data variability related to each patient's placebo response.
Latest News and Events from Tools4Patient
Tools4Patient launches COV-IQ, a new platform aiming to evaluate the impact of COVID-19 on clinical trial patients. COV-IQ aims to quantify the effect of emotional stress, change in trial conduct and changes in social structure on each trial subject.Find out more...
This webinar will discuss the importance of considering patient psychological traits, expectations, perception of their relationship with the trial physician and staff, and social structure in efforts to understand the impact of the COVID-19 pandemic on clinical trials.Find out more...
Reducing clinical data variability. Empowering better decision making. Accelerating the launch of therapeutics to market.